A liver-specific mouse model for MYO5B-associated cholestasis reveals a toxic gain-of-function as underlying disease mechanism.
Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y, Chen K, Li F, Gu Z, Liu Q, He L, Shao T, Song Q, Zhu F, Zhang L, Jiang M, Zhou Y, Barve S, Zhang X, McClain CJ, Feng W.
Hepatology. 2020 Jun;71(6):2050-2066. doi: 10.1002/hep.30975. Epub 2020 Mar 16.
3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
Pose E, Sancho-Bru P, Coll M.
Methods Mol Biol. 2019;1981:249-257. doi: 10.1007/978-1-4939-9420-5_16.
Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms.
Sutton H, Karpen SJ, Kamath BM.
Annu Rev Pathol. 2024 Jan 24;19:319-344. doi: 10.1146/annurev-pathmechdis-031521-025623.
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
Paumgartner G, Beuers U.
Clin Liver Dis. 2004 Feb;8(1):67-81, vi. doi: 10.1016/S1089-3261(03)00135-1.
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
Danielsson O, Vesterinen T, Arola J, Åberg F, Nissinen MJ.
Eur J Gastroenterol Hepatol. 2024 Jul 1;36(7):961-969. doi: 10.1097/MEG.0000000000002785. Epub 2024 Apr 26.
Drug-induced hepatotoxicity.
Kaplowitz N, Aw TY, Simon FR, Stolz A.
Ann Intern Med. 1986 Jun;104(6):826-39. doi: 10.7326/0003-4819-104-6-826.
Changes in Protein Metabolism and Early Development of Sarcopenia in Mice With Cholestatic Liver Disease.
Agrifoglio O, Görs S, Sciascia Q, Li Z, Albrecht E, Achilles S, Statz M, Bastian M, Lindner T, Gauß KF, Rohde S, Rischmüller K, Berlin P, Lamprecht G, Jaster R, Metges CC, Ehlers L.
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13737. doi: 10.1002/jcsm.13737.
A liver-specific mouse model for MYO5B-associated cholestasis reveals a toxic gain-of-function as underlying disease mechanism.
She HY, Qiu YL, Feng JY, Cheng Y, Chi H, van IJzendoorn SCD, Xing QH, Wang JS.
Biochem Biophys Res Commun. 2025 Apr 12;758:151669. doi: 10.1016/j.bbrc.2025.151669. Epub 2025 Mar 20.
Fibrates and cholestasis.
Ghonem NS, Assis DN, Boyer JL.
Hepatology. 2015 Aug;62(2):635-43. doi: 10.1002/hep.27744. Epub 2015 Mar 23.
Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology.
Wu XN, Wang MZ, Zhang N, Zhang W, Dong J, Ke MY, Xiang JX, Ma F, Xue F, Hou JJ, Ma ZJ, Wang FM, Liu XM, Wu R, Pawlik TM, Ye K, Yu J, Zhang XF, Lyu Y.
J Hepatol. 2024 Jun;80(6):928-940. doi: 10.1016/j.jhep.2024.01.036. Epub 2024 Feb 8.
